vs
Apellis Pharmaceuticals, Inc.（APLS）与GORMAN RUPP CO（GRC）财务数据对比。点击上方公司名可切换其他公司
Apellis Pharmaceuticals, Inc.的季度营收约是GORMAN RUPP CO的1.2倍（$199.9M vs $166.6M），GORMAN RUPP CO净利率更高（8.3% vs -29.5%，领先37.7%），GORMAN RUPP CO同比增速更快（2.4% vs -5.9%），GORMAN RUPP CO自由现金流更多（$10.2M vs $-14.3M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs 2.3%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
戈尔曼-拉普是一家总部位于俄亥俄州曼斯菲尔德的泵类制造商，产品面向市政供水、污水处理、工业、建筑、石油、消防及原始设备制造等多个领域提供配套水泵，公司在纽约证券交易所上市，现任首席执行官为斯科特·金。
APLS vs GRC — 直观对比
营收规模更大
APLS
是对方的1.2倍
$166.6M
营收增速更快
GRC
高出8.3%
-5.9%
净利率更高
GRC
高出37.7%
-29.5%
自由现金流更多
GRC
多$24.4M
$-14.3M
两年增速更快
APLS
近两年复合增速
2.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $166.6M |
| 净利润 | $-59.0M | $13.7M |
| 毛利率 | — | 31.4% |
| 营业利润率 | -25.6% | 14.9% |
| 净利率 | -29.5% | 8.3% |
| 营收同比 | -5.9% | 2.4% |
| 净利润同比 | -62.2% | 25.2% |
| 每股收益（稀释后） | $-0.40 | $0.53 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSGRC
| Q4 25 | $199.9M | $166.6M | ||
| Q3 25 | $458.6M | $172.8M | ||
| Q2 25 | $178.5M | $179.0M | ||
| Q1 25 | $166.8M | $163.9M | ||
| Q4 24 | $212.5M | $162.7M | ||
| Q3 24 | $196.8M | $168.2M | ||
| Q2 24 | $199.7M | $169.5M | ||
| Q1 24 | $172.3M | $159.3M |
净利润APLSGRC
| Q4 25 | $-59.0M | $13.7M | ||
| Q3 25 | $215.7M | $11.3M | ||
| Q2 25 | $-42.2M | $15.8M | ||
| Q1 25 | $-92.2M | $12.1M | ||
| Q4 24 | $-36.4M | $11.0M | ||
| Q3 24 | $-57.4M | $12.9M | ||
| Q2 24 | $-37.7M | $8.3M | ||
| Q1 24 | $-66.4M | $7.9M |
毛利率APLSGRC
| Q4 25 | — | 31.4% | ||
| Q3 25 | — | 29.2% | ||
| Q2 25 | — | 31.3% | ||
| Q1 25 | — | 30.7% | ||
| Q4 24 | — | 30.2% | ||
| Q3 24 | — | 31.3% | ||
| Q2 24 | — | 31.9% | ||
| Q1 24 | — | 30.4% |
营业利润率APLSGRC
| Q4 25 | -25.6% | 14.9% | ||
| Q3 25 | 48.7% | 12.4% | ||
| Q2 25 | -18.6% | 15.0% | ||
| Q1 25 | -50.0% | 13.5% | ||
| Q4 24 | -12.3% | 13.0% | ||
| Q3 24 | -24.0% | 14.2% | ||
| Q2 24 | -14.7% | 15.4% | ||
| Q1 24 | -36.0% | 12.8% |
净利率APLSGRC
| Q4 25 | -29.5% | 8.3% | ||
| Q3 25 | 47.0% | 6.6% | ||
| Q2 25 | -23.6% | 8.8% | ||
| Q1 25 | -55.3% | 7.4% | ||
| Q4 24 | -17.1% | 6.7% | ||
| Q3 24 | -29.2% | 7.7% | ||
| Q2 24 | -18.9% | 4.9% | ||
| Q1 24 | -38.5% | 5.0% |
每股收益（稀释后）APLSGRC
| Q4 25 | $-0.40 | $0.53 | ||
| Q3 25 | $1.67 | $0.43 | ||
| Q2 25 | $-0.33 | $0.60 | ||
| Q1 25 | $-0.74 | $0.46 | ||
| Q4 24 | $-0.30 | $0.42 | ||
| Q3 24 | $-0.46 | $0.49 | ||
| Q2 24 | $-0.30 | $0.32 | ||
| Q1 24 | $-0.54 | $0.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $35.1M |
| 总债务越低越好 | — | $307.5M |
| 股东权益账面价值 | $370.1M | $414.7M |
| 总资产 | $1.1B | $860.1M |
| 负债/权益比越低杠杆越低 | — | 0.74× |
8季度趋势，按日历期对齐
现金及短期投资APLSGRC
| Q4 25 | $466.2M | $35.1M | ||
| Q3 25 | $479.2M | $42.9M | ||
| Q2 25 | $370.0M | $27.0M | ||
| Q1 25 | $358.4M | $21.8M | ||
| Q4 24 | $411.3M | $24.2M | ||
| Q3 24 | $396.9M | $39.7M | ||
| Q2 24 | $360.1M | $34.2M | ||
| Q1 24 | $325.9M | $27.8M |
总债务APLSGRC
| Q4 25 | — | $307.5M | ||
| Q3 25 | — | $322.3M | ||
| Q2 25 | — | $337.1M | ||
| Q1 25 | — | $352.2M | ||
| Q4 24 | — | $366.6M | ||
| Q3 24 | — | $381.0M | ||
| Q2 24 | — | $395.4M | ||
| Q1 24 | $93.1M | $400.7M |
股东权益APLSGRC
| Q4 25 | $370.1M | $414.7M | ||
| Q3 25 | $401.2M | $405.2M | ||
| Q2 25 | $156.3M | $397.8M | ||
| Q1 25 | $164.2M | $382.1M | ||
| Q4 24 | $228.5M | $373.8M | ||
| Q3 24 | $237.1M | $367.3M | ||
| Q2 24 | $264.3M | $358.6M | ||
| Q1 24 | $266.7M | $353.7M |
总资产APLSGRC
| Q4 25 | $1.1B | $860.1M | ||
| Q3 25 | $1.1B | $869.9M | ||
| Q2 25 | $821.4M | $861.8M | ||
| Q1 25 | $807.3M | $857.8M | ||
| Q4 24 | $885.1M | $858.5M | ||
| Q3 24 | $901.9M | $883.5M | ||
| Q2 24 | $904.5M | $891.1M | ||
| Q1 24 | $831.9M | $887.4M |
负债/权益比APLSGRC
| Q4 25 | — | 0.74× | ||
| Q3 25 | — | 0.80× | ||
| Q2 25 | — | 0.85× | ||
| Q1 25 | — | 0.92× | ||
| Q4 24 | — | 0.98× | ||
| Q3 24 | — | 1.04× | ||
| Q2 24 | — | 1.10× | ||
| Q1 24 | 0.35× | 1.13× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $15.0M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $10.2M |
| 自由现金流率自由现金流/营收 | -7.1% | 6.1% |
| 资本支出强度资本支出/营收 | 0.1% | 2.9% |
| 现金转化率经营现金流/净利润 | — | 1.09× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $88.9M |
8季度趋势，按日历期对齐
经营现金流APLSGRC
| Q4 25 | $-14.2M | $15.0M | ||
| Q3 25 | $108.5M | $42.3M | ||
| Q2 25 | $4.4M | $27.8M | ||
| Q1 25 | $-53.4M | $21.1M | ||
| Q4 24 | $19.4M | $9.3M | ||
| Q3 24 | $34.1M | $27.2M | ||
| Q2 24 | $-8.3M | $22.7M | ||
| Q1 24 | $-133.0M | $10.7M |
自由现金流APLSGRC
| Q4 25 | $-14.3M | $10.2M | ||
| Q3 25 | $108.3M | $35.8M | ||
| Q2 25 | $4.4M | $24.8M | ||
| Q1 25 | $-53.4M | $18.1M | ||
| Q4 24 | $19.3M | $5.2M | ||
| Q3 24 | — | $24.0M | ||
| Q2 24 | $-8.4M | $19.4M | ||
| Q1 24 | $-133.3M | $6.8M |
自由现金流率APLSGRC
| Q4 25 | -7.1% | 6.1% | ||
| Q3 25 | 23.6% | 20.7% | ||
| Q2 25 | 2.5% | 13.9% | ||
| Q1 25 | -32.0% | 11.0% | ||
| Q4 24 | 9.1% | 3.2% | ||
| Q3 24 | — | 14.3% | ||
| Q2 24 | -4.2% | 11.5% | ||
| Q1 24 | -77.3% | 4.3% |
资本支出强度APLSGRC
| Q4 25 | 0.1% | 2.9% | ||
| Q3 25 | 0.0% | 3.8% | ||
| Q2 25 | 0.0% | 1.7% | ||
| Q1 25 | 0.0% | 1.8% | ||
| Q4 24 | 0.0% | 2.5% | ||
| Q3 24 | 0.0% | 1.9% | ||
| Q2 24 | 0.0% | 1.9% | ||
| Q1 24 | 0.2% | 2.5% |
现金转化率APLSGRC
| Q4 25 | — | 1.09× | ||
| Q3 25 | 0.50× | 3.73× | ||
| Q2 25 | — | 1.76× | ||
| Q1 25 | — | 1.74× | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | — | 2.10× | ||
| Q2 24 | — | 2.72× | ||
| Q1 24 | — | 1.36× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
GRC
| Industrial | $34.7M | 21% |
| Fire Market | $31.4M | 19% |
| Municipal | $25.3M | 15% |
| Agriculture | $22.5M | 14% |
| Repair Parts | $18.9M | 11% |
| Construction | $17.3M | 10% |
| Original Equipment Manufacturer | $10.8M | 7% |
| Petroleum | $5.6M | 3% |
